Agathe is Regulatory Affairs Director, AstraZeneca.
- Meeting Report
HM8: Enhancing dialogue to foster innovation
Susan Bhatti welcomed the speakers and highlighted the importance of having an iterative, responsive and holistic regulatory dialogue with a flexible scientific advice process and an alignment across the stakeholders. The recent example of the pandemic has emphasised the importance of having proactive measures and time-efficient interactions with health authorities.